Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors

Clinical trial NCT07071103 · RECRUITING

Trial details

NCT number: NCT07071103
Sponsor: Chuangzhen Chen
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Radiotherapy Metastatic Solid Cancers Immune Checkpoint Blockade Esophageal Neoplasms Malignant Lung Neoplasm Malignant Drug Resistance

Start date: 2025-09-26
Primary completion: 2028-01-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.